Aurobindo Pharma Limited (AUROPHARMA.NS)
INR 1266.0
(1.48%)
INR 1266.0
(1.48%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 55.65 Billion INR | -38.64% |
| 2022 | 108.1 Billion INR | 8.88% |
| 2021 | 99.28 Billion INR | -2.46% |
| 2020 | 101.79 Billion INR | 12.34% |
| 2019 | 90.61 Billion INR | 25.76% |
| 2018 | 72.04 Billion INR | 16.6% |
| 2017 | 61.79 Billion INR | 19.11% |
| 2016 | 51.87 Billion INR | 12.1% |
| 2015 | 46.27 Billion INR | 9.89% |
| 2014 | 42.11 Billion INR | 64.73% |
| 2013 | 25.56 Billion INR | 21.86% |
| 2012 | 20.97 Billion INR | 30.9% |
| 2011 | 16.02 Billion INR | 25.34% |
| 2010 | 12.78 Billion INR | 10.13% |
| 2009 | 11.61 Billion INR | -8.32% |
| 2008 | 12.66 Billion INR | 86.81% |
| 2007 | 6.77 Billion INR | 10.85% |
| 2006 | 6.11 Billion INR | 191.88% |
| 2005 | 2.09 Billion INR | -56.7% |
| 2004 | 4.83 Billion INR | 19.44% |
| 2003 | 4.05 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 18.02 Billion INR | -40.64% |
| 2023 Q2 | 29.28 Billion INR | 4.17% |
| 2023 Q3 | 29.42 Billion INR | 0.49% |
| 2023 Q4 | 18.05 Billion INR | -38.63% |
| 2023 FY | 66.33 Billion INR | -38.64% |
| 2023 Q1 | 28.11 Billion INR | 0.72% |
| 2022 FY | 108.1 Billion INR | 8.88% |
| 2022 Q2 | 25.66 Billion INR | -1.46% |
| 2022 Q1 | 26.04 Billion INR | 3.68% |
| 2022 Q3 | 28.47 Billion INR | 10.93% |
| 2022 Q4 | 27.91 Billion INR | -1.98% |
| 2021 Q2 | 24.91 Billion INR | 4.0% |
| 2021 Q3 | 25.27 Billion INR | 1.45% |
| 2021 Q4 | 25.12 Billion INR | -0.61% |
| 2021 Q1 | 23.95 Billion INR | 0.77% |
| 2021 FY | 99.28 Billion INR | -2.46% |
| 2020 Q2 | 26.86 Billion INR | 10.75% |
| 2020 Q3 | 26.88 Billion INR | 0.08% |
| 2020 FY | 101.79 Billion INR | 12.34% |
| 2020 Q4 | 23.77 Billion INR | -11.58% |
| 2020 Q1 | 24.26 Billion INR | 0.83% |
| 2019 Q1 | 22.4 Billion INR | 33.06% |
| 2019 FY | 90.61 Billion INR | 25.76% |
| 2019 Q4 | 24.06 Billion INR | 5.69% |
| 2019 Q3 | 22.76 Billion INR | -1.36% |
| 2019 Q2 | 23.08 Billion INR | 3.01% |
| 2018 Q1 | 17.18 Billion INR | -0.8% |
| 2018 FY | 72.04 Billion INR | 16.6% |
| 2018 Q4 | 16.83 Billion INR | -13.94% |
| 2018 Q3 | 19.56 Billion INR | 5.98% |
| 2018 Q2 | 18.46 Billion INR | 7.44% |
| 2017 Q1 | 14.7 Billion INR | -3.11% |
| 2017 FY | 61.79 Billion INR | 19.11% |
| 2017 Q4 | 17.32 Billion INR | 6.2% |
| 2017 Q3 | 16.31 Billion INR | -3.07% |
| 2017 Q2 | 16.82 Billion INR | 14.43% |
| 2016 Q3 | 14.12 Billion INR | 6.5% |
| 2016 FY | 51.87 Billion INR | 12.1% |
| 2016 Q2 | 13.26 Billion INR | 1.56% |
| 2016 Q1 | 13.06 Billion INR | -4.32% |
| 2016 Q4 | 15.17 Billion INR | 7.42% |
| 2015 Q2 | 11.81 Billion INR | 0.39% |
| 2015 Q4 | 13.65 Billion INR | 12.04% |
| 2015 Q3 | 12.18 Billion INR | 3.11% |
| 2015 Q1 | 11.76 Billion INR | 7.37% |
| 2015 FY | 46.27 Billion INR | 9.89% |
| 2014 Q1 | 9.63 Billion INR | 45.93% |
| 2014 FY | 42.11 Billion INR | 64.73% |
| 2014 Q4 | 10.96 Billion INR | 1.24% |
| 2014 Q3 | 10.82 Billion INR | 1.27% |
| 2014 Q2 | 10.69 Billion INR | 11.01% |
| 2013 FY | 25.56 Billion INR | 21.86% |
| 2013 Q4 | 6.6 Billion INR | -2.22% |
| 2013 Q1 | 5.88 Billion INR | 25.55% |
| 2013 Q2 | 6.32 Billion INR | 7.55% |
| 2013 Q3 | 6.75 Billion INR | 6.65% |
| 2012 FY | 20.97 Billion INR | 30.9% |
| 2012 Q4 | 4.68 Billion INR | -20.5% |
| 2012 Q3 | 5.89 Billion INR | 6.52% |
| 2012 Q1 | 4.86 Billion INR | 32.36% |
| 2012 Q2 | 5.53 Billion INR | 13.86% |
| 2011 Q3 | 4.43 Billion INR | 0.0% |
| 2011 Q4 | 3.67 Billion INR | -17.11% |
| 2011 FY | 16.02 Billion INR | 25.34% |
| 2010 FY | 12.78 Billion INR | 10.13% |
| 2009 FY | 11.61 Billion INR | -8.32% |
| 2008 FY | 12.66 Billion INR | 86.81% |
| 2007 FY | 6.77 Billion INR | 10.85% |
| 2006 FY | 6.11 Billion INR | 191.88% |
| 2005 FY | 2.09 Billion INR | -56.7% |
| 2004 FY | 4.83 Billion INR | 19.44% |
| 2003 FY | 4.05 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -9498.06% |
| Ind-Swift Limited | 946.56 Million INR | -5779.975% |
| Bajaj HealthCare Limited | 985.34 Million INR | -5548.57% |
| Sakar Healthcare Limited | 204.07 Million INR | -27172.723% |
| Innova Captab Limited | 931.03 Million INR | -5878.1% |
| Divi's Laboratories Limited | 14.17 Billion INR | -292.787% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -2150.168% |
| Morepen Laboratories Limited | 1.98 Billion INR | -2700.468% |
| Mankind Pharma Limited | 29.27 Billion INR | -90.135% |
| Sequent Scientific Limited | 2.9 Billion INR | -1818.041% |
| Wanbury Limited | 978.96 Million INR | -5585.376% |
| Laurus Labs Limited | 11.9 Billion INR | -367.329% |
| Nectar Lifesciences Limited | 932.7 Million INR | -5867.396% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -378.132% |
| Alembic Limited | 872.45 Million INR | -6279.436% |
| Hikal Limited | 4.46 Billion INR | -1146.873% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -250.718% |
| Neuland Laboratories Limited | 2.92 Billion INR | -1799.752% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -276.256% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | -18.541% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -2428.755% |
| Themis Medicare Limited | 1.12 Billion INR | -4843.862% |
| RPG Life Sciences Limited | 1.63 Billion INR | -3303.112% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 55.549% |
| Lupin Limited | 125.09 Billion INR | 55.508% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -2557.923% |
| Wockhardt Limited | 8.48 Billion INR | -556.343% |
| Vaishali Pharma Limited | 84.02 Million INR | -66136.537% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -1710.366% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -12591.346% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -285.069% |
| FDC Limited | 3.49 Billion INR | -1490.336% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 41.949% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -13395.212% |
| Eris Lifesciences Limited | 4.94 Billion INR | -1026.008% |
| Venus Remedies Limited | 1.91 Billion INR | -2804.47% |
| ZIM Laboratories Limited | 1.01 Billion INR | -5394.049% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -3821.719% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -95387.719% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -2459.572% |
| Shilpa Medicare Limited | 3.33 Billion INR | -1569.314% |
| Albert David Limited | 1.02 Billion INR | -5323.969% |
| Ajanta Pharma Limited | 30.46 Billion INR | -82.708% |
| Hester Biosciences Limited | 908.84 Million INR | -6024.059% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -3867.66% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -2079.159% |
| Gufic Biosciences Limited | 1.18 Billion INR | -4590.579% |
| Windlas Biotech Limited | 1 Billion INR | -5429.791% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -1758.112% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -391498.537% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -34208.442% |
| Granules India Limited | 10.31 Billion INR | -439.697% |
| Aarti Drugs Limited | 1.16 Billion INR | -4667.358% |
| Bal Pharma Limited | 555.62 Million INR | -9917.152% |
| Alkem Laboratories Limited | 32.83 Billion INR | -69.508% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 63.901% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -5081.402% |
| Medicamen Biotech Limited | 335.16 Million INR | -16506.02% |
| Unichem Laboratories Limited | 6.72 Billion INR | -727.52% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -12116.798% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -815998.24% |
| Valiant Laboratories Limited | 138.02 Million INR | -40223.338% |
| Orchid Pharma Limited | 800.77 Million INR | -6850.539% |
| Medico Remedies Limited | 59.67 Million INR | -93168.37% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -2520.201% |
| Ipca Laboratories Limited | 18.98 Billion INR | -193.128% |
| Brooks Laboratories Limited | 51.18 Million INR | -108649.316% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -16003.179% |
| Piramal Enterprises Limited | 63.65 Billion INR | 12.56% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -159.815% |
| NATCO Pharma Limited | 10.05 Billion INR | -453.369% |
| Suven Life Sciences Limited | 109.75 Million INR | -50613.349% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -120486.489% |
| Strides Pharma Science Limited | 9.16 Billion INR | -507.466% |
| Indoco Remedies Limited | 12.06 Billion INR | -361.462% |
| Alpa Laboratories Limited | 127.38 Million INR | -43594.379% |
| Lasa Supergenerics Limited | 291.17 Million INR | -19014.997% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -1708.954% |